Program of the 7th AMR Conference
Conference Day 1
Thursday, 16 March 2023
09:00 – 11:00
Pre-conference meeting
Room Kairo
BEAM Alliance General Assembly
11:00 – 11:30
Networking break
11:30 – 13:00
Pre-conference workshop
Room Shanghai
Promise of artificial intelligence to antibacterial drug discovery
co-organized by:
Moderator:
- Ursula Theuretzbacher (Center for Anti-Infective Agents)
Speakers:
- Denise Barrault (Exscientia)
- Jitao David Zhang (F. Hoffmann-La Roche)
- Nikolaus Stiefl (Novartis)
14:00 – 15:30
Opening session
Room Shanghai
Solving the AMR pandemic: where do we stand?
Moderator:
- Marc Gitzinger (BioVersys & BEAM Alliance)
Speakers:
- John Alter (AMR Action Fund)
- Rachel Silverman Bonnifield (Center for Global Development)
- Mariano Votta (ACN)
- Kristine Peers (EFPIA)
- Wolfgang Philipp (European Commission)
- Antoni Torres (Hospital Clínic of Barcelona)
16:00 – 17:30
Parallel tracks
Room Shanghai
National efforts on pull incentives: latest updates
Moderator:
- Kevin Outterson (CARB-X & Boston University)
Speakers:
- Senator Todd Young (US Congress)
- Tetsuya Itani (Japanese Ministry of Health, Labour and Welfare)
- Thomas D. Hälbig (German National Association of Statutory Health Insurance Funds)
- Joel Denis (Public Health Agency Canada)
- Rachel Silverman Bonnifield (Center for Global Development)
Room Delhi
Novel tools in pre-clinical development
Moderator:
- Pete Jackson (Infex Therapeutics & BEAM Alliance)
Speakers:
- Urs Jenal (NCCR Antiresist)
- Giancarlo Biagini (iiCON)
- Maria Uria-Nickelsen (CARB-X)
- Shampa Das (Liverpool University)
- Radu Botgros (European Medicines Agency)
- Rakel Arrazuria (Paul-Ehrlich-Institut & AMR Accelerator)
- Remko van Leeuwen (Madam Therapeutics)
Room Kairo
Advancing the biological pipeline against AMR pathogens
Moderator:
- Bernhard Kerscher (Paul-Ehrlich-Institute)
Speakers:
- Ed Buurman (CARB-X)
- Hasan Jafri (Aridis Pharmaceuticals)
- Dominik Gary (Research Centre for medical technology and biotechnology)
- Jan Poolman (Janssen Vaccines & Prevention)
18:00 – 19:30
Start-up pitch
Room Shanghai
hosted by INCATE
Moderator:
Douglas Häggström (INCATE)
Running order of pitching companies:
1) iFast Diagnostics
2) MyxoBiomedical
3) Oxford SimCell
4) Spartha Medical
5) Betatide
6) AbGenics
7) Genova Therapeutics
8) EVIIVE
9) EpyNext Therapeutics
10) Disperazol
11) Fagoterapia
Conference Day 2
Friday, 17 March 2023
08:30 – 10:00
Parallel tracks
Room Shanghai
How to improve the success rate of clinical trials in unmet medical needs populations
Moderator:
- Glenn Dale (BioVersys)
Speakers:
- Marlieke De Kraker (University of Geneva)
- John Rex (F2G)
- Radu Botgros (European Medicines Agency)
- David Paterson (National University of Singapore)
- Matteo Bassetti (University of Genoa)
Room Delhi
Breakthrough from early-stage research
Moderator:
- Christoph Dehio (NCCR AntResist)
Speakers:
- Zemer Gitai (Princeton University & ArrePath)
- Nassos Typas (EMBL)
- Priscille Brodin (INSERM)
Room Kairo
Antimicrobials in the environment: time for action
Moderator:
- Cees de Joncheere (WHO)
Speakers:
- Dominic O’Neil (QIAGEN)
- Steve Brooks (AMR Industry Alliance)
- Joakim Larsson (University of Gothenburg)
- Valeria Gigante (WHO)
10:30 – 12:00
Plenary session
Room Shanghai
AMR India pavilion – challenges and opportunities for providing global solutions
Moderator:
- Anand Anandkumar (Bugworks)
Speakers:
- Yann Ferrisse (GARDP)
- Jaideep Gogtay (Cipla Pharma)
- Taslimarif Saiyed (Centre for Cellular and Molecular Platforms (C-CAMP))
- Kamini Walia (Indian Council of Medical Research – ICMR)
- Camilla Rodrigues (Hinduja Hospital Mumbai)
13:30 – 14:30
Parallel tracks
Room Shanghai
Investing in AMR Innovation: How to get prepared for the future and restore value creation perspectives in the field?
Moderator:
- Florence Séjourné (Aurobac Therapeutics & BEAM Alliance)
Speakers:
- Martin Heidecker (AMR Action Fund)
- Wolfgang Philipp (European Commission)
- Bita Sehat (TRILL Impact)
- Camilla Petrycer Hansen (Novo REPAIR Impact Fund)
- Fei Shen (Boehringer Ingelheim Venture Fund)
Room Delhi
Towards better treatment combination against tuberculosis
Moderator:
- Martin Boeree (Radboud University)
Speakers:
- Santiago Ferrer Bazaga (ISCIII)
- Ainhoa Lucia Quintana (University of Zaragoza)
- Norbert Heinrich (Ludwig-Maximilian-University, Munich)
- Samuel Schumacher (WHO)
Room Kairo
Antifungals: back to menu
Moderator:
- Mark Jones (Basilea & BEAM Alliance)
Speakers:
- Hatim Sati (WHO)
- John Rex (F2G)
- Werner Heinz (Caritas Hospital)
15:00 – 16:00
Parallel tracks
Room Shanghai
Push landscape: are all the gaps filled?
Moderator:
- Remko van Leeuwen (Madam Therapeutics & BEAM Alliance)
Speakers:
- Ralf Sudbrak (Global AMR R&D Hub)
- Douglas Häggström (INCATE)
- Anders Karlén (Uppsala University)
- Su Chiang (CARB-X)
- Beverly Isherwood (MD Catapult)
- Cornelis Boersma (NADP)
Room Delhi
Leveraging diagnostics to improve the development and appropriate use of antimicrobials
Moderator:
- Betsy Wonderly Trainor (CARB-X)
Speakers:
- Amir Nakar (MeMed)
- Chantal Morel (University of Bern)
- Theresa Liebe (Blink)
- Jeroen Nieuwland (Llusern Scientific)
Room Kairo
Technology updates
Moderator:
- Morgane Vanbiervliet (Debiopharm)
Speakers:
- Natalie D’Amore (Seres Therapeutics)
- David Cameron (Debiopharm)
- Delphine Croisier (Vivexia)
- Christian Röhrig (Micreos)
- Kwangmin Son (PhAST)
16:30 – 17:30
Closing session
Room Shanghai
AMR to do list: homework to avoid the disaster
Moderator:
- Deborah O’Neil (NovaBiotics & BEAM Alliance)
Speakers:
- James Anderson (IFPMA)
- Flic Gabbay (Transcrip)
- Alexandra Cameron (WHO)
- Seamus O’Brien (GARDP)